| [1] |
Selianitis D, Pispas S. P, (MMA-co-HPMA)-b-POEGMA copolymers: synthesis, micelle formation in aqueous media and drug encapsulation [J]. Polymer International, 2021, 70(10): 1508-1522.
|
| [2] |
Jianfeng W, Cui Y, Guping T, et al. Glucose-functionalized multidrug- conjugating nanoparticles based on amphiphilic terpolymer with enhanced anti-tumorous cell cytotoxicity [J]. International Journal of Pharmaceutics, 2013, 441(2): 291-298.
|
| [3] |
M. Ghezzi, S. Pescina, C. Padula, et al. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions [J]. Journal of Controlled Release, 2021, 332(10): 312-336.
|
| [4] |
Neha R, Rakesh P, Jasmine K K, et al. Polycaprolactone- based materials in wound healing applications, 2022, 79: 7041–7063.
|
| [5] |
高扬, 陈磊, 杨来侠, 等. 聚己内酯药物控释载体结构及制备方法研究进展 [J]. 高分子通报, 2021(09): 19-30.
|
| [6] |
Kim M, Park S Y, Jin M L, et al. Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages [J]. Immunopharmacology and immunotoxicology, 2015, 37(5): 473-480.
|
| [7] |
Sang J, Dhakal S, Lee Y. Cucurbitacin B Suppresses Hyperglycemia Associated with a High Sugar Diet and Promotes Sleep in Drosophila melanogaster [J]. Molecules and cells, 2021, 44(2): 68-73.
|
| [8] |
Dai S, Wang C, Zhao X, et al. Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics [J]. Pharmacol Res, 2023, 187, 106587.
|
| [9] |
Yuan R, Zhao W, Wang Q Q, et al. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis [J]. Pharmacological research, 2021, 170: 105748.
|
| [10] |
Ma W, Xiang Y, Yang R, et al. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t (8; 21) acute myeloid leukemia [J]. Journal of Pharmacological Sciences, 2019, 139(4): 304-310.
|
| [11] |
Leng J, Dai X, Cheng X, et al. Biomimetic Cucurbitacin B-Polydopamine Nanoparticles for Synergistic Chemo-Photothermal Therapy of Breast Cancer [J]. Front Bioeng Biotechnol. 2022, 10, 841186.
|
| [12] |
Bakar Ates F, Ozkan E, Sengel Turk C T. Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage [J]. International Journal of Pharmaceutics, 2020, 586: 119565.
|
| [13] |
胡瑞瑞, 张家梁, 郝海军. 葫芦素B磷脂复合物纳米结构脂质载体的制备 [J]. 中成药, 2019, 41(11): 2571-2576.
|
| [14] |
方宁. 葫芦素B-聚乳酸-羟基乙酸共聚物载药纳米粒的构建与药效学评价 [J]. 药物评价研究, 2019, 42(08): 1557-1562.
|
| [15] |
Wang Q, Zhang C. Inhibitory Role of Cucurbitacin B with Polylactic Acid Nanoparticles Carrying Long Non-Coding RNA (LncRNA) Cancer Susceptibility Candidate 2c (CASC2c) in Oral Cancer Cell Migration and Invasion Through Targeting of Signal Transcription and Activator of Transcription (STAT) Signaling Pathway [J]. Science of Advanced Materials, 2021, 13(10): 1892-1898.
|
| [16] |
贾莉, 陈文, 赵辉. HPLC法测定葫芦素胶束药物含量测定 [J]. 齐齐哈尔医学院学报, 2013, 34(15): 2270-2271.
|
| [17] |
肖艳, 陈洋, 严金良, 等. 不同内核结构PEG-b-PCL胶束的制备及其载药性能的研究 [J]. 高分子学报, 2015(05): 524-534.
|
| [18] |
胡慧中, 郑晓君, 胡巧红. 姜黄素—甘草次酸-PEI-PLGA纳米粒的制备及工艺优化 [J]. 山东医药, 2015, 55(16): 8-11.
|
| [19] |
杨君, 梁慧敏, 丁平田, 等. 聚合物载药胶束的制剂学性质考察 [J]. 实用药物与临床, 2014, 17(12): 1578-1581.
|